ClinicalTrials.gov - Information on Clinical Trials and Human Research Studies: Browse: North American Brain Tumor Consortium


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Browse : By Sponsor : University/Organization : North American Brain Tumor Consortium

Include trials that are no longer recruiting patients.

18 studies were found.
1. Recruiting Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
2. Recruiting CCI-779 in Treating Patients With Malignant Glioma
Conditions: adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; Mixed Gliomas
3. Recruiting Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
Conditions: adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; adult meningeal tumors; Mixed Gliomas
4. No longer recruiting Fenretinide in Treating Patients With Recurrent Malignant Glioma
Conditions: recurrent adult brain tumor; adult anaplastic oligodendroglioma; adult anaplastic astrocytoma; Mixed Gliomas
5. Recruiting FR901228 in Treating Patients With Progressive High-Grade Glioma
Conditions: adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; adult meningeal tumors; Mixed Gliomas
6. Recruiting Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors
Condition: adult brain tumor
7. No longer recruiting Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma
Conditions: recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; Mixed Gliomas
8. Completed Gene Therapy in Treating Patients With Recurrent Malignant Gliomas
Conditions: recurrent adult brain tumor; adult anaplastic oligodendroglioma; adult glioblastoma multiforme; adult anaplastic astrocytoma; Mixed Gliomas
9. Recruiting Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma
Condition: adult brain tumor
10. Recruiting Imatinib Mesylate in Treating Patients With Recurrent Meningioma
Conditions: adult meningioma; recurrent adult brain tumor; grade III meningioma; grade I meningioma; grade II meningioma
11. Completed Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma
Conditions: Adult Oligodendroglioma; recurrent adult brain tumor; adult brain stem glioma; adult infiltrating astrocytoma; Mixed Gliomas
12. Completed O(6)-benzylguanine in Treating Patients With Malignant Glioma
Conditions: adult glioblastoma multiforme; adult anaplastic astrocytoma; recurrent adult brain tumor
13. Recruiting Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma
Conditions: adult anaplastic astrocytoma; Mixed Gliomas; adult anaplastic oligodendroglioma; recurrent adult brain tumor; adult anaplastic ependymoma
14. No longer recruiting Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma
Conditions: adult glioblastoma multiforme; adult anaplastic astrocytoma; Mixed Gliomas; recurrent adult brain tumor
15. Recruiting Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma
Conditions: adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; Mixed Gliomas
16. Completed Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor
Conditions: recurrent adult brain tumor; adult glioblastoma multiforme
17. Recruiting Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Conditions: adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
18. No longer recruiting Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma
Conditions: recurrent adult brain tumor; adult glioblastoma multiforme

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services

1.	Recruiting	Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Conditions: adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
2.	Recruiting	CCI-779 in Treating Patients With Malignant Glioma Conditions: adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; Mixed Gliomas
3.	Recruiting	Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma Conditions: adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; adult meningeal tumors; Mixed Gliomas
4.	No longer recruiting	Fenretinide in Treating Patients With Recurrent Malignant Glioma Conditions: recurrent adult brain tumor; adult anaplastic oligodendroglioma; adult anaplastic astrocytoma; Mixed Gliomas
5.	Recruiting	FR901228 in Treating Patients With Progressive High-Grade Glioma Conditions: adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; adult meningeal tumors; Mixed Gliomas
6.	Recruiting	Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors Condition: adult brain tumor
7.	No longer recruiting	Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma Conditions: recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; Mixed Gliomas
8.	Completed	Gene Therapy in Treating Patients With Recurrent Malignant Gliomas Conditions: recurrent adult brain tumor; adult anaplastic oligodendroglioma; adult glioblastoma multiforme; adult anaplastic astrocytoma; Mixed Gliomas
9.	Recruiting	Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma Condition: adult brain tumor
10.	Recruiting	Imatinib Mesylate in Treating Patients With Recurrent Meningioma Conditions: adult meningioma; recurrent adult brain tumor; grade III meningioma; grade I meningioma; grade II meningioma
11.	Completed	Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma Conditions: Adult Oligodendroglioma; recurrent adult brain tumor; adult brain stem glioma; adult infiltrating astrocytoma; Mixed Gliomas
12.	Completed	O(6)-benzylguanine in Treating Patients With Malignant Glioma Conditions: adult glioblastoma multiforme; adult anaplastic astrocytoma; recurrent adult brain tumor
13.	Recruiting	Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma Conditions: adult anaplastic astrocytoma; Mixed Gliomas; adult anaplastic oligodendroglioma; recurrent adult brain tumor; adult anaplastic ependymoma
14.	No longer recruiting	Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma Conditions: adult glioblastoma multiforme; adult anaplastic astrocytoma; Mixed Gliomas; recurrent adult brain tumor
15.	Recruiting	Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma Conditions: adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; Mixed Gliomas
16.	Completed	Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor Conditions: recurrent adult brain tumor; adult glioblastoma multiforme
17.	Recruiting	Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Conditions: adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
18.	No longer recruiting	Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma Conditions: recurrent adult brain tumor; adult glioblastoma multiforme